Optima Medical Innovations Corp.
Optima Medical Innovations Corp.
Optima Medical Innovations Corp. has three primary business segments: (1) Multidisciplinary specialty pain clinics with a focus on the treatment of chronic pain, including controlled applications of medical cannabis in Canada. Through an exclusive strategic alliance with Jack Nathan Medical Inc., the Company has access to one of the largest healthcare systems across Canada and Internationally for its education and research platform (currently over 1.5 million patient visits annually); (2) Development of formulated products for therapeutic purposes and natural health product alternatives at its manufacturing facility in Spokane. The Company also has research agreements with multiple universities for medical cannabis research and development of new medical grade products; and (3) Distribution and sale of hemp-based cannabidiol (“CBD”) products in the United States, Canada, Europe, Brazil and China. The CBD product line contains EVR Premium Hemp Oil, which is an organically grown and non-GMO.
Optima Medical Innovations Corp. (OMIC)
SEDAR Information
Information d'entreprise
Capitalisation
Company Officers
Communiqués de presse
Bulletins
2024-0104 - Radiation - Optima Medical Innovations Corp. (OMIC)
le 5 janvier/January 2024
The common shares of Optima Medical Innovations Corp. will be delisted from the CSE at market close today, January 5, 2024.
Optimia Medical Innovations Corp. is currently suspended. See bulletin 2022-0504.
___________________________